Fox K, Deanfield J, Krikler S, Ribeiro P, Wright C
Br J Clin Pharmacol. 1984;17 Suppl 1(Suppl 1):92S-93S. doi: 10.1111/j.1365-2125.1984.tb02437.x.
The importance of the interaction between smoking and propranolol (metabolised in the liver) and atenolol (excreted almost entirely in the urine) was investigated in a double-blind placebo-controlled trial. Resting and exercise heart rates were significantly greater during smoking than no-smoking phases. Atenolol and propranolol significantly improved ST segment response after exercise whether or not the patients were smoking. Plasma propranolol significantly increased when patients stopped smoking whereas there was no such change in atenolol levels.
在一项双盲安慰剂对照试验中,研究了吸烟与普萘洛尔(在肝脏中代谢)和阿替洛尔(几乎完全经尿液排泄)之间相互作用的重要性。吸烟期间的静息心率和运动心率显著高于不吸烟阶段。无论患者是否吸烟,阿替洛尔和普萘洛尔均能显著改善运动后的ST段反应。患者戒烟后,血浆普萘洛尔显著升高,而阿替洛尔水平无此变化。